In this report, we describe a case with metastatic castration-resistant prostate cancer (mCRPC) and peripancreatic lymph node metastases who developed acute pancreatitis following [177Lu] Lu-PSMA-617 therapy. This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.